PETVIVO HOLDINGS INC WTS - PETVW STOCK NEWS

PetVivo Holdings, a biomedical device company focused on innovative therapeutics for pets, will present at the Aegis Capital Virtual Conference from May 2nd to 4th, 2023. CEO John Lai will discuss the company's Spryng product featuring OsteoCushion Technology, aimed at managing lameness and joint issues in companion animals.

Spryng is an injectable device that supports joint health by mimicking natural cartilage and is currently available for sale. The presentation is scheduled for May 3rd, 2023, from 12:25 PM to 12:55 PM ET. PetVivo holds a strong patent portfolio, with 17 products in development and a unique market strategy focused on veterinary devices.

PetVivo Holdings (NASDAQ: PETV, PETVW) has appointed Mary Grace Rutland as the new Business Development Manager for the Mid-Atlantic Region. Rutland, with 24 years of experience in animal health sales, will focus on promoting Spryng with OsteoCushion technology to veterinarians across the U.S. CEO John Lai expressed excitement about her addition, highlighting her previous roles in the industry, including positions at Fort Dodge Animal Health and Neogen Corporation. PetVivo specializes in innovative medical devices for companion animals, with Spryng aimed at treating lameness and joint-related conditions like osteoarthritis in dogs and horses. The company has a pipeline of 17 products and holds 19 patents covering its biomaterials and methods.

PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) announces its participation at the ACVSMR Symposium from April 28-29, 2023, in Charleston, South Carolina. The company will showcase its lead product, SPRYNG™ with OsteoCushion™ Technology, designed for managing joint afflictions in pets, particularly osteoarthritis. This event provides a platform for PetVivo to demonstrate its innovative veterinary medical device to experts in the field. CEO John Lai emphasized the importance of this opportunity to discuss how Spryng can enhance the quality of life for companion animals. The company’s focus is on leveraging human therapies for veterinary applications, with a pipeline containing seventeen products and a portfolio of nineteen patents.

PetVivo Holdings (NASDAQ: PETV, PETVW) has appointed Spencer Breithaupt to its Board of Directors, bringing over 30 years of experience in the animal health industry. Breithaupt, previously with MWI Animal Health and Fortune 500 companies, is expected to enhance the company's industry relationships and strategic direction. CEO John Lai expressed confidence that Breithaupt's expertise will be instrumental in advancing PetVivo’s mission. The company specializes in biomedical devices for companion animals and currently offers its lead product, SPRYNG with OsteoCushion technology, which is designed to manage joint-related afflictions in animals.

PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) has announced its participation as a Platinum Sponsor at the International Veterinary Academy of Pain Management (IVAPM) Pain Management Forum from April 2-4, 2023, in Atlanta, Georgia. The company will showcase its lead product, SPRYNG™ with OsteoCushion™ Technology, designed to manage lameness and joint-related issues, particularly osteoarthritis. CEO John Lai emphasizes the forum as a crucial opportunity to present the benefits of SPRYNG to veterinary pain management experts. PetVivo is focused on the commercialization of innovative medical devices for companion animals and has a pipeline of seventeen products.

PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) announced the completion of the first cohort of a clinical study on Spryng™ with OsteoCushion™ Technology, targeting dogs with cruciate ligament injuries. Dr. Erik Kleeman presented these results at the Veterinary Orthopedic Society conference, highlighting a 64% response rate and a 51% mean pain score improvement in the cohort of 22 dogs. This study suggests that Spryng™ may serve as an effective option for managing lameness and joint conditions in companion animals. PetVivo aims to leverage human therapies for companion animal treatments efficiently.

PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) is showcasing its innovative product, SPRYNG™ with OsteoCushion™ Technology, at the Veterinary Orthopedic Society Annual Conference from March 11-18, 2023, in Big Sky, Montana. SPRYNG™ is an injection-based treatment targeting lameness and joint issues like osteoarthritis in companion animals. CEO John Lai expressed excitement for the opportunity to connect with veterinary professionals. Additionally, Dr. Erik Kleeman will present research on intra-articular injections for dogs with cruciate ligament injuries on March 17, 2023. PetVivo focuses on developing advanced biomedical devices for animal care, with a pipeline of seventeen products and nineteen patents.